Colorectal cancer Posts - Page 26 of 68 on Medivizor
Navigation Menu

Colorectal cancer Posts on Medivizor

Post-surgery complications can affect chemotherapy treatment after surgery in colorectal cancer

Posted by on Sep 28, 2017 in Colorectal cancer | 0 comments

In a nutshell This study investigated the post-surgery factors that affect the use of chemotherapy after surgery in colorectal cancer patients. Researchers suggested that post-surgery complications are associated with delay or not receiving chemotherapy treatment.   Some background Surgery and post-surgery chemotherapy are the standard...

Read More

Bevacizumab plus chemotherapy improves outcomes in metastatic colorectal cancer

Bevacizumab plus chemotherapy improves outcomes in metastatic colorectal cancer

Posted by on Aug 21, 2017 in Colorectal cancer | 0 comments

In a nutshell This study compared the effectiveness of the combined treatment with chemotherapy and bevacizumab (Avastin) to chemotherapy alone in advanced colorectal cancer. Researchers suggested that the combination therapy improves the treatment of these patients. Some background Colorectal cancer is one of the most common cancers causing death...

Read More

Is targeted chemotherapy for stage II/III rectal cancer before surgery effective?

Is targeted chemotherapy for stage II/III rectal cancer before surgery effective?

Posted by on Aug 19, 2017 in Colorectal cancer | 0 comments

In a nutshell This study examined the effect of pre-surgical chemotherapy without radiotherapy in stage II/III rectal cancer. The study showed that combined targeted chemotherapy was effective in these patients. Some background Rectal cancer is a cancer of the end part of the digestive system. In stage II and III, the cancer has begun to...

Read More

FDA News Releases and Signing Up for Alerts

FDA News Releases and Signing Up for Alerts

Posted by on Aug 13, 2017 in Benign prostatic hyperplasia, Blog, Breast cancer, Colorectal cancer, Coronary artery disease, Diabetes mellitus, Erectile dysfunction, Hodgkin's lymphoma, Hypertension, Infertility, Kidney stones, Leukemia, Lung cancer, Lymphoma, Melanoma, Multiple Myeloma, Non-Hodgkin lymphoma, Prostate cancer, Rheumatoid Arthritis, Stroke, Urinary incontinence, Urinary tract infection | 1 comment

You may not know this but you can get warnings from the FDA on problems with prescription medications and over-the-counter drugs.  For example, on August 11, a FDA News Release issued this warning about over-the-counter liquid vitamins that are given to young children and those who cannot swallow pills. “The U.S. Food and Drug Administration is...

Read More

How to Smoothie!

How to Smoothie!

Posted by on Jul 25, 2017 in Blog, Breast cancer, Colorectal cancer, Hodgkin's lymphoma, Leukemia, Lung cancer, Lymphoma, Melanoma, Multiple Myeloma, Non-Hodgkin lymphoma, Prostate cancer | 1 comment

This summer has been a challenge after a family member with celiac disease had a gluten exposure (Click here to read more about celiac disease). Gluten damages the small intestine villi (see 5 Facts You Probably Didn’t Know About Your Small Intestines), which are essential for nutrition absorption.  For over a month, gastrointestinal pain, vomiting...

Read More

Infographic on Cancer Immunotherapy

Infographic on Cancer Immunotherapy

Posted by on Jul 12, 2017 in Blog, Breast cancer, Colorectal cancer, Hodgkin's lymphoma, Leukemia, Lung cancer, Lymphoma, Melanoma, Multiple Myeloma, Non-Hodgkin lymphoma, Prostate cancer | 5 comments

Last summer we provided a series of posts on oncology basics.  Oncology Basics: Preparing for ASCO covered some of the history of oncology.  In Understanding Cells, we reviewed what is newly understood about cells–it’s way beyond what you learned in high school biology.  DNA with lots of animated videos also explained some of the basics...

Read More

mFOLFOX plus panitumumab is associated with an improved tumor response in metastatic colorectal cancer patients

mFOLFOX plus panitumumab is associated with an improved tumor response in metastatic colorectal cancer patients

Posted by on Jul 11, 2017 in Colorectal cancer | 0 comments

In a nutshell This study investigated the tumor response and overall survival in colorectal cancer patients treated with mFOLFOX6 and bevacizumab (Avastin) or panitumumab (Vectibix). Researchers suggested that mFOLFOX+panitumumab is associated with an improved response.  Some background The standard treatment for metastatic (spread to other...

Read More